Doron Shorrer Net Worth

The estimated Net Worth of Doron Shorrer is at least $484 Thousand dollars as of 8 April 2019. Mr. Shorrer owns over 14,286 units of Pluri Inc stock worth over $464,744 and over the last 17 years he sold PSTI stock worth over $18,766. In addition, he makes $0 as Lead Independent Director at Pluri Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Shorrer PSTI stock SEC Form 4 insiders trading

Doron has made over 4 trades of the Pluri Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently he bought 14,286 units of PSTI stock worth $10,000 on 8 April 2019.

The largest trade he's ever made was buying 14,286 units of Pluri Inc stock on 8 April 2019 worth over $10,000. On average, Doron trades about 2,090 units every 138 days since 2007. As of 8 April 2019 he still owns at least 464,744 units of Pluri Inc stock.

You can see the complete history of Mr. Shorrer stock trades at the bottom of the page.

Doron Shorrer biography

Doron Shorrer CPA serves as Lead Independent Director of the Company. Mr. Shorrer has served as the Chairman and CEO of Shorrer International Ltd., an investment and financial consulting company. Mr. Shorrer also serves as a director at each of Sigma Mutual Funds Ltd., Food Save Ltd. and G.D.M. Investments Ltd. Mr. Shorrer has served as a director of Provident Fund for employees of the Israel Electric Company Ltd. and between 1999 and 2004 he was Chairman of the board of directors of Phoenix Insurance Company, one of the largest insurance companies in Israel, and of Mivtachim Pension Funds Group, the largest pension fund in Israel. Prior to serving in these positions, Mr. Shorrer held senior positions that included Arbitrator at the Claims Resolution Tribunal for Dormant Accounts in Switzerland; Economic and Financial Advisor, Commissioner of Insurance and Capital Markets for the State of Israel; Member of the board of directors of “Nechasim” of the State of Israel; Member Committee for the Examination of Structural Changes in the Capital Market (The Brodet Committee); General Director of the Ministry of Transport; founder and managing partner of an accounting firm with offices in Jerusalem, Tel-Aviv and Haifa; Member of the Lecture Staff of the Hebrew University Business Administration School; Chairman of Amal School Chain; Chairman of a Public Committee for Telecommunications; and Economic Consultant to the Ministry of Energy. In addition, Mr. Shorrer served as a director of Hebrew University employees and Massad Bank from the International Bank group from 2009 to 2018.

How old is Doron Shorrer?

Doron Shorrer is 67, he's been the Lead Independent Director of Pluri Inc since 2006. There are 1 older and 5 younger executives at Pluri Inc. The oldest executive at Pluri Inc is Mark Germain, 69, who is the Independent Director.

What's Doron Shorrer's mailing address?

Doron's mailing address filed with the SEC is MATAM PARK, BUILDING #5, , HAIFA, L3, 3508409.

Insiders trading at Pluri Inc

Over the last 17 years, insiders at Pluri Inc have traded over $7,081,854 worth of Pluri Inc stock and bought 2,345,914 units worth $14,327,834 . The most active insiders traders include Wolf Capital Limited Part..., Zami Aberman, and Israel Ben Yoram. On average, Pluri Inc executives and independent directors trade stock every 64 days with the average trade being worth of $54,123. The most recent stock trade was executed by Zami Aberman on 10 February 2022, trading 80,616 units of PSTI stock currently worth $145,109.

What does Pluri Inc do?

Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented PLX cell product candidates and is currently conducting late-stage clinical trials in several indications. PLX cell product candidates are believed to release a range of therapeutic proteins in response to inflammation, muscle trauma, hematological disorders and radiation damage. The cells are grown using the Company's proprietary three-dimensional expansion technology and can be administered to patients off- the-shelf, without tissue matching. Pluristem has a strong intellectual property position; a

Complete history of Mr. Shorrer stock trades at Pluri Inc

Pluri Inc executives and stock owners

Pluri Inc executives and other stock owners filed with the SEC include:

• Yaacov Yanay,
  Pres, CEO & Director
• Zalman Aberman,
  Executive Chairman of the Board
• Yaky Yanay,
  President, Chief Executive Officer, Director
• Chen Franco-Yehuda,
  Chief Financial Officer, Treasurer, Secretary
• Dana Rubin,
  Director of Investor Relations
• Moria Kwiat,
  Independent Director
• Mark Germain,
  Independent Director
• Isaac Braun,
  Independent Director
• Doron Shorrer,
  Lead Independent Director
• Dr. Nitsan Halevy M.D.,
  Chief Medical Officer
• Efrat Livne-Hadass,
  VP of HR
• Lior Raviv,
  Chief Technology Officer
• Israel Ben Yoram,
  Director
• Nachum Rosman,
  Director
• Hava Meretzki,
  Director
• Erez Egozi,
  Chief Financial Officer
• Shai Pines,
  Director
• Boaz Gur Lavie,
  CFO
• Wolf Capital Limited Part...,
  10% owner
• Maital Shemesh Rasmussen,
  Director
• Rami Avraham Levi,
  Director
• Pinhas Doron Birger,
  Director
• Varda Shalev,
  Director
• Zami Aberman,
  Director